Why Ultragenyx Stock Might Be Ready to Climb
JPMorgan is optimistic about Ultragenyx's drug setrusumab (UX143) and expects big gains ahead of key study updates.
NOTRELOAD AI
Major Step Forward for Taysha's TSHA-102 Gene Therapy in Rett Syndrome
The FDA has granted Breakthrough Therapy designation to TSHA-102 for Rett Syndrome, acknowledging its potential to redefine treatment.
Fermi Rides AI Energy Wave to $19.3 Billion Debut Amidst Race for Power
Amarillo, Texas-based Fermi Inc., co-founded by Rick Perry, saw shares surge 55% in its IPO, capitalizing on the booming demand for power infrastructure to support global AI growth, despite lacking current revenue.
FICO Revolutionizes Mortgage Scoring: Direct Licensing and Pricing Transparency for Lenders
FICO sells mortgage scores directly to lenders, cutting out credit bureaus. This seeks price transparency & savings but hurt bureau stock.
First Solar Gains After Jefferies Price Target Hike
First Solar stock rose after a PT hike ($260) by Jefferies. Capacity is sold out until 2028. Almost all analysts say buy.
GoodRx and Kroger Partner for Instant Drug Savings
GoodRx and Kroger launched RxSmartSaver at 2,200 pharmacies. Scan a code for instant discounts on brand drugs like Ozempic and Lantus.